Global Leading Market Research Publisher QYResearch announces the release of its latest report “Composite Films and Bags for Pharmaceutical Packaging – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Composite Films and Bags for Pharmaceutical Packaging market, including market size, share, demand, industry development status, and forecasts for the next few years.
Addressing core industry needs: Pharmaceutical products require protection from moisture, oxygen, and light – but single-layer plastic films lack sufficient barrier performance. Composite films and bags solve this with multi-layer laminates combining different materials (plastic, aluminum, paper) for enhanced barrier properties, puncture resistance, and chemical durability. Key challenges include delamination, heat seal consistency, and recyclability.
The global market for Composite Films and Bags for Pharmaceutical Packaging was estimated to be worth US$ 9,145 million in 2025 and is projected to reach US$ 12,710 million, growing at a CAGR of 4.9% from 2026 to 2032. In 2024, the average global price is approximately US$ 2,800 per ton, with an annual sales volume of about 3.12 million tons.
Composite films and bags for pharmaceutical packaging are multi-layer laminated materials designed to meet the storage and transportation requirements of medicines. They combine barrier properties, moisture resistance, puncture resistance, and chemical durability, effectively preventing the ingress of light, oxygen, and moisture to protect drug stability and safety, and are widely used for packaging solid preparations, liquid formulations, and sterile products.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6095806/composite-films-and-bags-for-pharmaceutical-packaging
Market Segmentation & Key Players
The Composite Films and Bags for Pharmaceutical Packaging market is segmented as below:
Leading Suppliers: Constantia Flexibles, West Pharmaceutical Services, TOPPAN, Loparex, ZACROS, Amcor, Super Olefins, Jiangsu Zhongjin Matai, Shanghai Kindly, Shandong Huazhilin Pharmaceutical Technology, Sichuan Hui Li Industry, Harbin Pengcheng New Materials, Shandong Ujoin Medical Technology, Sunkey Packaging, Hubei Hongyu New Packaging Materials, Baoli Packaging, Hengshui Jiecai.
Segment by Type: Plastic (multi-layer all-polymer) | Aluminum-Plastic (with aluminum foil barrier) | Others
Segment by Application: Oral | Injection | Topical | Others
Exclusive Industry Insights
Discrete lamination processes: Composite films are manufactured via adhesive lamination, extrusion lamination, or solventless lamination. Aluminum-plastic composites (aluminum foil sandwiched between polymer layers) offer the highest barrier (nearly zero oxygen/ moisture transmission). Typical structures: PET/Al/PE, PET/metallized PET/PE.
Technical differentiation – barrier types:
- Plastic Composites (42% revenue): PET/PE, PET/EVOH/PE. High clarity, moderate barrier (0.5–5 cc/m²/day oxygen). Suitable for oral solids, non-critical applications.
- Aluminum-Plastic Composites (55% revenue): PET/Al/PE, paper/Al/PE. Highest barrier (<0.01 cc/m²/day oxygen). Light-proof, puncture-resistant. Preferred for moisture-sensitive drugs, sterile products.
Recent 6-month data (Oct 2025 – Mar 2026):
- Oral applications largest segment (48% revenue) – blister packs, strip packs, sachets.
- Aluminum-plastic composites fastest-growing (CAGR 5.5%), driven by high-potency APIs and biologics.
- Recyclable mono-material composites (all-PE without aluminum) grew 28% YoY.
User case – Oral solid dose manufacturer (India, 50 billion tablets/year): Converting from PVC blister to aluminum-plastic cold-form foil (PET/Al/PE) extended moisture-sensitive drug shelf life from 18 to 36 months. Product expansion into tropical markets (high humidity) became viable. Additional packaging cost: US$ 0.002 per tablet; revenue gain from new markets: US$ 45M annually.
Application insights: Oral (48%) – tablet blister packs, powder sachets, granule strip packs. Injection (22%) – sterile barrier pouches for prefilled syringes, IV bag overwraps. Topical (18%) – ointment tube laminates, cream sachets. Others (12%) – diagnostic kit pouches, device packaging.
Critical performance requirements:
- Oxygen transmission rate (OTR): <0.1 cc/m²/day (Al-plastic), <5 cc/m²/day (all-plastic).
- Moisture vapor transmission rate (MVTR): <0.1 g/m²/day (Al-plastic), <2 g/m²/day (all-plastic).
- Heat seal strength: >25 N/15mm.
- Puncture resistance: >10 N.
Regional snapshot: Asia-Pacific leads with 52% revenue share (China 28%, India 15%), driven by generic drug manufacturing. North America holds 22%, Europe 18% (sustainable packaging focus).
Conclusion
The composite films and bags market grows steadily, driven by moisture-sensitive drug protection, sterile product requirements, and barrier performance demands. Success depends on delamination control, aluminum-free recyclable alternatives, and heat seal consistency. The projected US$ 12.71 billion market by 2032 appears achievable.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
